Adam S. Kibel
Brigham and Women's Hospital
665 Papers
3.4K Citations
Adam S. Kibel is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 65, co-authored 523 publications. Previous affiliations of Adam S. Kibel include Beth Israel Deaconess Medical Center & Harvard University.
Chat about Author
Papers
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy
Matthew Mossanen,Matthew Mossanen,Kenneth G. Nepple,Robert L. Grubb,Gerald L. Androile,Dorina Kallogjeri,Eric A. Klein,Andrew J. Stephenson,Adam S. Kibel,Adam S. Kibel +9 more
TL;DR: Heterogeneity in outcomes existed, depending on the pretreatment definition of high-risk PC, and clinical stage T3 and Gleason score 8-10 were most strongly associated with PCSM and OM.
28
The effect of treatment at minority-serving hospitals on outcomes for bladder cancer
Sean A. Fletcher,Philipp Gild,Alexander P. Cole,Malte W. Vetterlein,Adam S. Kibel,Toni K. Choueiri,Guru Sonpavde,Mark A. Preston,Daniel Pucheril,Mani Menon,Maxine Sun,Stuart R. Lipsitz,Quoc-Dien Trinh +12 more
TL;DR: Black patients suffered worse survival and were less likely to receive definitive treatment for bladder cancer regardless of the type of hospital in which they were treated, and there was no difference between minority-serving and nonminority-serving hospitals in overall survival or receipt of definitive treatment.
28
Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis.
Matthew Mossanen,Matthew Mossanen,Ross Krasnow,Dimitar V. Zlatev,Wei Shen Tan,Wei Shen Tan,Mark A. Preston,Mark A. Preston,Quoc-Dien Trinh,Quoc-Dien Trinh,Adam S. Kibel,Adam S. Kibel,Guru Sonpavde,Deborah Schrag,Benjamin I. Chung,Steven L. Chang,Steven L. Chang,Steven L. Chang +17 more
TL;DR: To examine the incidence of perioperative complications after radical cystectomy and assess their impact on 90‐day postoperative mortality during the index stay and upon readmission, a large number of patients were referred for surgery.
28
Mutational analysis of ETV6 in prostate carcinoma
TL;DR: 43 prostate cell lines, xenografts, and metastatic foci are analyzed for inactivating mutations of ETV6, an attractive candidate prostate cancer tumor suppressor gene since as it previously has been implicated in malignancy.
27